Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy

MLA

Luis Fayad, et al. “Response-Adapted Radiation Therapy for Newly Diagnosed Primary Diffuse Large B-Cell Lymphoma of the CNS Treated with Methotrexate-Based Systemic Therapy.” Advances in Radiation Oncology, vol. 3, no. 4, Oct. 2018, pp. 639–46. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0386a606f6ef279382fb156c467b6fdf&authtype=sso&custid=ns315887.

APA

Luis Fayad, Sattva S. Neelapu, Michelle A. Fanale, Bouthaina S. Dabaja, Amin M. Alousi, Sarah A. Milgrom, Tommy Sheu, Chitra Hosing, Nathan Fowler, Sairah Ahmed, T.Y. Andraos, Fredrick B. Hagemeister, Yago Nieto, Chelsea C. Pinnix, Jillian R. Gunther, Yasuhiro Oki, Loretta J. Nastoupil, L. Jeffrey Medeiros, & Linda Chi. (2018). Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy. Advances in Radiation Oncology, 3(4), 639–646.

Chicago

Luis Fayad, Sattva S. Neelapu, Michelle A. Fanale, Bouthaina S. Dabaja, Amin M. Alousi, Sarah A. Milgrom, Tommy Sheu, et al. 2018. “Response-Adapted Radiation Therapy for Newly Diagnosed Primary Diffuse Large B-Cell Lymphoma of the CNS Treated with Methotrexate-Based Systemic Therapy.” Advances in Radiation Oncology 3 (4): 639–46. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0386a606f6ef279382fb156c467b6fdf&authtype=sso&custid=ns315887.